|
Volumn 81, Issue 1, 2010, Pages 70-73
|
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
TOPIRAMATE;
ABDOMINAL PAIN;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL GLOBAL IMPRESSION SCALE;
CLINICAL TRIAL;
COGNITIVE DEFECT;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DIARRHEA;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
GILLES DE LA TOURETTE SYNDROME;
HEADACHE;
HUMAN;
HYPERSOMNIA;
MALE;
MULTICENTER STUDY;
NEPHROLITHIASIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SYMPTOM;
TIC;
TOTAL MOTOR TIC SCORE;
TOTAL PHONIC TIC SCORE;
TREATMENT RESPONSE;
WEIGHT CHANGE;
YALE GLOBAL TIC SEVERITY SCALE;
ADOLESCENT;
ADULT;
AGED;
CHILD;
DOUBLE-BLIND METHOD;
FEMALE;
FRUCTOSE;
HUMANS;
MALE;
MIDDLE AGED;
NEUROPROTECTIVE AGENTS;
SEVERITY OF ILLNESS INDEX;
TOURETTE SYNDROME;
YOUNG ADULT;
|
EID: 73449102162
PISSN: 00223050
EISSN: 1468330X
Source Type: Journal
DOI: 10.1136/jnnp.2009.185348 Document Type: Article |
Times cited : (145)
|
References (10)
|